PNC Financial Services Group Inc. lifted its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 7.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 203,508 shares of the company’s stock after purchasing an additional 14,872 shares during the period. PNC Financial Services Group Inc.’s holdings in GE HealthCare Technologies were worth $16,692,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds have also modified their holdings of the stock. Western Wealth Management LLC increased its stake in shares of GE HealthCare Technologies by 2.4% during the fourth quarter. Western Wealth Management LLC now owns 5,240 shares of the company’s stock worth $430,000 after purchasing an additional 125 shares in the last quarter. United Community Bank increased its stake in shares of GE HealthCare Technologies by 10.2% during the fourth quarter. United Community Bank now owns 1,410 shares of the company’s stock worth $116,000 after purchasing an additional 130 shares in the last quarter. Thoma Capital Management LLC increased its stake in shares of GE HealthCare Technologies by 1.4% during the fourth quarter. Thoma Capital Management LLC now owns 9,918 shares of the company’s stock worth $814,000 after purchasing an additional 136 shares in the last quarter. Colonial Trust Advisors increased its stake in shares of GE HealthCare Technologies by 11.1% during the third quarter. Colonial Trust Advisors now owns 1,391 shares of the company’s stock worth $104,000 after purchasing an additional 139 shares in the last quarter. Finally, Norinchukin Bank The increased its stake in shares of GE HealthCare Technologies by 0.4% during the third quarter. Norinchukin Bank The now owns 38,913 shares of the company’s stock worth $2,922,000 after purchasing an additional 149 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.
Insiders Place Their Bets
In other news, CFO James Saccaro purchased 3,310 shares of the company’s stock in a transaction dated Friday, May 1st. The stock was acquired at an average price of $60.60 per share, with a total value of $200,586.00. Following the purchase, the chief financial officer directly owned 87,471 shares in the company, valued at approximately $5,300,742.60. This represents a 3.93% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Peter J. Arduini purchased 4,169 shares of the company’s stock in a transaction dated Thursday, April 30th. The stock was purchased at an average cost of $59.92 per share, with a total value of $249,806.48. Following the purchase, the chief executive officer owned 259,424 shares in the company, valued at approximately $15,544,686.08. This trade represents a 1.63% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Over the last 90 days, insiders have bought 11,847 shares of company stock worth $719,555. 0.36% of the stock is currently owned by company insiders.
GE HealthCare Technologies Stock Down 0.2%
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last announced its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The business had revenue of $5.13 billion for the quarter, compared to analysts’ expectations of $5.04 billion. During the same period in the prior year, the company posted $1.01 EPS. The firm’s revenue was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.89 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
Several analysts recently issued reports on the stock. BTIG Research dropped their price objective on shares of GE HealthCare Technologies from $85.00 to $80.00 and set a “buy” rating for the company in a research note on Wednesday, April 29th. Rothschild & Co Redburn dropped their price objective on shares of GE HealthCare Technologies from $110.00 to $98.00 in a research note on Thursday, April 30th. Argus dropped their price objective on shares of GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating for the company in a research note on Tuesday. Morgan Stanley upped their price objective on shares of GE HealthCare Technologies from $80.00 to $85.00 and gave the company an “equal weight” rating in a research note on Wednesday, February 4th. Finally, Wells Fargo & Company dropped their price objective on shares of GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating for the company in a research note on Thursday, April 30th. Nine analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and an average target price of $80.21.
Read Our Latest Analysis on GE HealthCare Technologies
GE HealthCare Technologies Profile
GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.
In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.
Read More
- Five stocks we like better than GE HealthCare Technologies
- SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?
- CAVA Group’s Stock Looks Delicious After Strong Earnings
- Lowe’s Finds Support at $215 After Q1 Earnings Sell-Off
- Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
